Loading clinical trials...
Loading clinical trials...
Double Blinded Randomized Clinical Trial for Evaluation of Resin Modified Glass Ionomer Cement Versus Resin Infiltration in Treating White Spot Lesions
The aim of this study is to evaluate the addition of new technology of resin modified glass-ionomer in comparison to resin infiltration in treating post-orthodontic white spot lesions; both applies into the same patient's mouth; to reveal which material will have more clinical satisfactory performance inside the oral cavity and to overcome the high expensive cost in treating such clinical cases
Roles and responsibilities: * Shaimaa Mohammed (SH.M.): Operator and author.Specialist in Air-Force Specialized Hospital. * Mohamed Riad (M.R.): Main supervisor, data monitoring and auditing, Professor, Conservative Dentistry Department,Cairo University. * Asma Harhash(A.H.):Co-supervisor, outcome assessor and data collection, Associate Professor, Russian University. * Omnia Magdy Moustafa (O.M.): Baseline data collection, recruitment, sequence generation, allocation concealment, patient retention and taking participants consents: Assistant lecturer, Conservative Dentistry Department , Faculty of Oral and Dental Medicine Cairo University. * Ghada Ahmed (G.A.): Data entry and auditing; Assistant lecturer, Conservative Dentistry Department, Faculty of Oral and Dental Medicine, Russian University. Intervention: A- Preoperative clinical assessment: 1. Explain patient need toward aesthetic needs 2. Digital photos for white spot lesions 3. Recording number of white spot lesions and site. (SH.M.) will apply both materials at the same patient mouth (Split mouth technique) according to the manufacturer's instructions. * Intervention: resin modified glass ionomer cement varnish: Vanish™ xt Extended Contact Varnish (3M ESPE Dental) * Comparator: resin infiltration (Dental Milestones Guaranteed, Germany). (A.H) and (SH.M) will assess the outcome measures through the follow up time: immediately after,1 day, 1 week,1 month,3 months, 6 months, 12 months
Age
0 - 35 years
Sex
ALL
Healthy Volunteers
Yes
Start Date
January 1, 2017
Primary Completion Date
January 1, 2018
Completion Date
May 1, 2018
Last Updated
September 23, 2016
35
ESTIMATED participants
Vanish xt Extended Contact Varnish
DRUG
resin infiltration
DRUG
Lead Sponsor
Cairo University
NCT06696105
NCT06824493
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions